Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 68,730 shares at $15.49 ($1.0M) on 2019-06-24, disclosed to the SEC on 2019-06-28.
Open-market sale of $1.0M STML by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.49 | 9,107 | $141K | 13.6% |
| 2 | $15.49 | 9,107 | $141K | 13.6% |
| 3 | $15.07 | 25,500 | $384K | 37.1% |
| 4 | $14.77 | 12,508 | $185K | 17.8% |
| 5 | $14.77 | 12,508 | $185K | 17.8% |
| Total | $15.07 avg | 68,730 |
| $1.0M |
| 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |